Condition

Head &Amp clinical trials and research

• 8Clinical trials
• 6Countries

Newest Head &Amp clinical trials

All recruiting trials (8)

• Rice bran for radiation-related mouth sores in head and neck cancer

  This trial will try rice bran supplements during radiation to see if adults with head and neck cancer have fewer or less severe mouth sores.

  Recruiting German University in Cairo · Cairo · NCT07242859

• Rice bran for radiation-related mouth sores in head and neck cancer

  This trial will try rice bran supplements during radiation to see if adults with head and neck cancer have fewer or less severe mouth sores.

  Recruiting German University in Cairo · Cairo · NCT07242859

• Pravastatin for long-term swallowing problems after head and neck radiotherapy

  This study will test whether taking pravastatin daily for 12 months can improve long-term swallowing problems in people who had radiotherapy for head and neck cancer.

  Recruiting Phase 2 Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT07217938

• Zanidatamab for solid tumors with HER2 changes

  This study will try zanidatamab, an anti-HER2 drug, in adults with advanced endometrial, colorectal, head and neck, sarcoma, or non-small cell lung cancer whose tumors have specific HER2 changes.

  Recruiting at 2 sites Phase 2 Unicancer · Angers and 3 other locations · NCT07192068

• 177Lu-BetaBart treatment for relapsed, inoperable, or metastatic solid tumors

  This trial will test a radioactive antibody called 177Lu-BetaBart in adults whose solid tumors have progressed after prior treatment, including castration-resistant prostate, colorectal, lung, ovarian, or cervical cancer.

  Recruiting at 5 sites Phase 1/2 Radiopharm Theranostics, Ltd · Dothan, Alabama and 4 other locations · NCT07189871

• Proactive risk-based coordination to shorten time from surgery to post-operative radiation for head and neck cancer

  This pilot tests whether an automated care-coordination system (PRONTO-HN) can help adults with oral or laryngeal squamous cell carcinoma begin post-operative radiotherapy within 42 days after surgery.

  Recruiting Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT07180901

• Tislelizumab with chemotherapy given before surgery in 2 or 4 cycles for locally advanced, resectable head and neck squamous cell cancer

  This trial tests whether 2 or 4 cycles of neoadjuvant tislelizumab plus chemotherapy can be given safely and more effectively before surgery.

  Recruiting Phase 2 Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07147426

• Reversing radiotherapy-related fibrosis and lymphedema in head and neck cancer survivors

  This trial will test whether adding one of several drugs (pravastatin, pentoxifylline, ketoprofen, or pirfenidone) to standard care can prevent or reduce radiation-related fibrosis and lymphedema in people treated for head and neck cancer.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT06912763

Related topics

Quick answers

How many Head &Amp clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (2 trials), Egypt (2 trials), France (1 trial), China (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →